CXCR2-IN-3

CXCR2-IN-3 is a CXCR2 inhibitor with an IC50 of 11.37 μM. It inhibits the CXCR2-Ca2+ signaling pathway, thereby blocking autophagic flux and promoting ROS-mediated apoptosis. Additionally, CXCR2-IN-3 suppresses the CXCR2-NLRP3 canonical pathway, reducing the expression of tumor-promoting markers. This compound induces autophagy-dependent cell death in polyploid giant cancer cells (PGCC) and is applicable in studies related to oral squamous cell carcinoma (OSCC) .